Is UnitedHealth Group Stock (NYSE:UNH) a Buy on the Dip?
UnitedHealth Is Maintained at Overweight by Barclays
UnitedHealth Group Analyst Ratings
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Cuts Target Price to $603
Barclays Reaffirms Their Buy Rating on UnitedHealth (UNH)
UnitedHealth Group Analyst Ratings
TD Cowen Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $609
unitedhealth's performance was downgraded by Deutsche Bank, Morgan Stanley, etc. target price.
TD Cowen Initiates UnitedHealth(UNH.US) With Buy Rating, Announces Target Price $609
UnitedHealth: Strategic Growth and Resilience Amid Challenges Justifies Buy Rating
HSBC Downgrades UnitedHealth(UNH.US) to Hold Rating, Raises Target Price to $595
A Quick Look at Today's Ratings for UnitedHealth(UNH.US), With a Forecast Between $595 to $650
HSBC Downgrades UnitedHealth to Hold From Buy, Cuts Price Target to $595 From $610
Bank of America lowered unitedhealth's target price to $650.
UnitedHealth Price Target Raised to $644.00/Share From $591.00 by Cantor Fitzgerald
Bernstein Adjusts Price Target on UnitedHealth to $658 From $654
A Quick Look at Today's Ratings for UnitedHealth(UNH.US), With a Forecast Between $595 to $650
UnitedHealth's Strategic Repositioning: Whit Mayo's Optimistic Buy Rating Amid Challenges
UnitedHealth Is Maintained at Buy by B of A Securities
UnitedHealth Group Analyst Ratings